Table 4

Factors associated with rebleeding—univariate model

Variable No rebleeding (n=51) Rebleeding (n=54) Relative hazard Lower 95% CI Upper 95% CI p Value
Median age (years)53 (25–79)51 (21–77)0.980.961.000.11
Sex
 Male33 (65%)35 (65%)1000
 Female18 (35%)19 (35%)0.970.551.700.91
Alcoholic cirrhosis34 (67%)34 (63%)1.150.662.020.63
Current variceal bleeding
 Non-active38 (75%)33 (61%)1000
 Active13 (26%)21 (39%)1.340.762.330.31
Previous long term treatment
 Drug 6 (12%) 5 (9%)0.990.392.500.98
 Endoscopic10 (20%)15 (28%)1.760.963.230.07
Oesophageal varices
 Large22 (43%)28 (52%)2.020.834.920.12
 Medium18 (35%)20 (37%)1.560.623.920.35
 Small11 (22%) 6 (11%)1000
Portal hypertensive gastropathy23 (45%)29 (54%)1.060.961.170.27
Gastric varices 4 (8%)10 (19%)1.920.963.840.07
Source of previous bleeding
 Oesophageal varices45 (88%)45 (83%)0.840.411.730.64
Treatment of the previous acute bleeding episode
 Medical28 (55%)23 (43%)1000
 Sclerotherapy23 (45%)31 (57%)1.690.972.930.06
Bilirubin (per 10 units)7-150 47.5 (38.9)60.0 (70.7)1.010.971.050.67
Prothrombin time7-150 16.7 (2.7)19.4 (14.1)1.051.021.080.0007
Albumin7-150 40.3 (39.4)36.5 (15.2)0.980.961.010.14
PSE44/6/145/7/21.100.572.130.77
Ascites33/6/1229/3/221.170.921.510.21
Median Child-Pugh score 8 (5–14) 8.5 (5–15)1.060.951.180.29
Median HVPG17 (7–44)17 (10–27)1.010.951.080.71
  • 7-150 Expressed as mean (SD).

  • CI, confidence interval; PSE, portosystemic encephalopathy.